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FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and
modulates cellular morphogenesis
Katarina Hattula and Johan Peränen
Huntington’s disease is characterised by the death of
cortical and striatal neurons, and is the result of an
expanded polyglutamine tract in the Huntingtin protein
[1]. Huntingtin is present on both endocytic and
secretory membrane organelles but its function is
unclear [2,3]. Rab GTPases regulate both of these
transport pathways [4]. We have previously shown that
Rab8 controls polarised membrane transport by
modulating cell morphogenesis [5]. To understand
Rab8-mediated processes, we searched for Rab8-
interacting proteins by the yeast two-hybrid system.
Here, we report that Huntingtin is linked to the Rab8
protein through FIP-2, a tumour necrosis factor-α
(TNF-α)-inducible coiled-coil protein related to the
NEMO protein [6,7]. The activated form of Rab8
interacted with the amino-terminal region of FIP-2,
whereas dominant-negative Rab8 did not. Huntingtin
bound to the carboxy-terminal region of FIP-2.
Coexpressed FIP-2 and Huntingtin enhanced the
recruitment of Huntingtin to Rab8-positive vesicular
structures, and FIP-2 promoted cell polarisation in a
similar way to Rab8. We propose a model in which
Huntingtin, together with FIP-2 and Rab8, are part of a
protein network that regulates membrane trafficking
and cellular morphogenesis.
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Results and discussion
About 25% of the positive clones isolated in a yeast two-
hybrid screen for Rab8-interacting proteins were identical
to FIP-2, a protein previously described as a E3-14.7K
binder; E3-14.7K is an adenoviral protein involved in pro-
tecting a cell against TNF-α-induced apoptosis [6]. We
found that FIP-2 was identical to a polypeptide (HYPL)
shown to interact with the amino-terminal part of Hunt-
ingtin [8]. So we then tested these interactions in the two-
hybrid system by pairwise transformations (not shown),
and we found that FIP-2 specifically interacts with wild-
type Rab8 and the active GTP-bound mutant Rab8-67L,
but not with the dominant-negative GDP-bound mutant
Rab8-22N. FIP-2 did not interact with Rab3A or Rab2,
suggesting that FIP-2 is highly specific for Rab8.
However, FIP-2 binds Rab8b, which is closely related to
Rab8 [9]. Rab8 and Rab8b differ only in their hypervari-
able region, making it unlikely that this region is essential
Figure 1
FIP-2 interacts with both Huntingtin and Rab8. (a) Deletion analysis of
FIP-2 to determine the regions that interact with Huntingtin and Rab8.
The FIP-2 fragments examined in the yeast two-hybrid assay are shown
below with the residue number of the first and last amino acids of each
truncated FIP-2 protein indicated; +, positive interaction; –, no
interaction. Light grey boxes, coiled-coil regions; blue boxes, leucine
zipper (LZ) regions; dark grey box, putative zinc finger region. Residues
411–577 were sufficient for interaction with Huntingtin, and residues
55–209 were required for interaction with Rab8. (b) In vitro and
in vivo interactions between FIP-2 and Rab8. The fusion protein
GST–FIP-2d was used for in vitro binding studies with in vitro
translated Rab8-22N (22N) and Rab8-67L (67L). Input in vitro
translated materials are shown in the first two lanes. GST indicates
control beads coupled to unfused GST protein. Only the in vitro
translated Rab8-67L interacted with GST–FIP-2d in this assay. (c) For
the in vivo binding studies, the construct encoding full-length FIP-2
was cotransfected into fibrosarcoma HT1080 cells with constructs
encoding either His–Rab8-22N or His–Rab8–67L. The material cross-
linked to His-tagged Rab8 proteins was eluted from metal-chelated
beads and analysed by western blotting using anti-FIP-2 and Rab8
antibodies. Lanes 1 and 2 show, respectively, the presence of
Rab8-22N or Rab8-67L in the input material. Lanes 3 and 4 show the
presence of FIP-2 crosslinked to Rab8-22N and Rab8-67L. The
molecular weights in (b,c) are in kDa.
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for FIP-2 binding. Full-length FIP-2 interacted with
Huntingtin1–588 as expected, whereas no interaction could
be detected between Huntingtin1–588 and any of the Rab8
constructs (data not shown).
To map the areas in FIP-2 that are involved in the
binding of Rab8 and Huntingtin, we generated a number
of FIP-2 deletion mutants and tested these in the two-
hybrid system (Figure 1a). This analysis demonstrated
that the amino-terminal region encompassing amino
acids 141–209 of FIP-2 is essential for Rab8 binding.
This region contains one of the leucine zipper domains
and is located inside the amino-terminal coiled-coil
region. We found that a region between amino acids
411–461 of FIP-2 is required for Huntingtin binding.
This region also contains a leucine zipper domain and is
part of the carboxy-terminal coiled-coil stretch. These
results indicate that Rab8 and Huntingtin bind distinct
regions of FIP-2. 
To analyse the interaction of Rab8 and FIP-2 in vitro, we
produced recombinant FIP-2 in Escherichia coli. Unfortu-
nately, both the full-length Rab8 and FIP-2 were insolu-
ble. However, a glutathione-S-transferase (GST) fusion
protein containing amino acids 58–209 of FIP-2
(GST–FIP-2d) was soluble. We incubated in vitro trans-
lated Rab8-22N and Rab8-67L with beads containing
GST–FIP-2d or GST alone. Only Rab8-67L bound
GST–FIP-2d, and no binding could be seen to GST
(Figure 1b). This result confirms those obtained with the
two-hybrid system and shows that only the GTP-bound
form of Rab8 interacts with FIP-2.
We also studied the interaction of Rab8 with FIP-2
in vivo by using cotransfection of HeLa cells with the T7
vaccinia system. For this purpose, we used constructs
expressing His-epitope-tagged Rab8-22N (His–Rab8-
22N) and Rab8-67L (His–Rab8-67L) under the control of
the T7 promoter. These constructs were mixed sepa-
rately with a similar plasmid encoding full-length FIP-2.
Post-nuclear fractions of these cells were chemically
crosslinked and then applied to Talon beads, which bind
the His-tagged Rab8 proteins. Western blots showed that
equivalent amounts of Rab8-22N and Rab8-67L were
expressed in these cells (Figure 1c). FIP-2 was readily
detected in the eluate of His–Rab8-67L beads, whereas
considerably smaller amounts of FIP-2 was eluted from
Rab8-22N, suggesting that the GTP-bound form of Rab8
is the preferred in vivo binding partner for FIP-2
(Figure 1c). 
We next determined how FIP-2, Huntingtin and Rab8
affect the localisation of each other in cells. We cotrans-
fected FIP-2, Huntingtin and Rab8 with each other in
HT1080 and HeLa cells, and analysed colocalisation by
confocal microscopy. When Huntingtin was expressed
alone in HT1080 cells, it was mainly found evenly dis-
tributed in the cytoplasm (Figure 2c). FIP-2 was also
found diffusely distributed in the cytoplasm, but a major
fraction of FIP-2 was associated with vesicular structures
near the nucleus (Figure 2d). In accordance with previous
studies, Rab8-67L was found on perinuclear vesicular
structures and in peripheral regions, and the majority of
Rab8-22N was confined to reticular structures around the
nucleus (Figure 2a,b).
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Figure 2
Coexpression of FIP-2, Huntingtin and Rab8
in HT1080 cells. After overnight transfection,
cells were fixed with paraformaldehyde,
permeabilised with 0.1% triton X-100 and
stained with the appropriate antibody (anti-
FIP-2, anti-Huntingtin) or localised as a green
fluorescent protein (GFP) fusion, and
analysed by confocal microscopy.
Transfection with only one construct was
done as control, as seen for (a) Rab8-67L,
(b) Rab8-22N, (c) Huntingtin and (d) FIP-2.
Colocalisation of (e,f) FIP-2 and Huntingtin,
and (g,h) FIP-2 and GFP–Rab8-67L was
detected (h) from the GFP fluorescence, or by
using antibodies to (e,g) FIP-2 and (f)
Huntingtin. (i,j) FIP-2 and Rab8-22N did not
colocalise as detected using antibodies to
(i) FIP-2 and (j) Rab8-22N. (k,l) Partial
colocalisation of Huntingtin and GFP–Rab8-
67L detected from (l) the GFP fluorescence,
and (k) using antibodies against Huntingtin.
Arrowheads indicate some of the structures
colocalising on the merged image (not
shown). The scale bars represent 5 µm.
(a) (b) (g) (h)
(c) (d) (i) (j)
(e) (f) (k) (l)
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Coexpression of Huntingtin with FIP-2 resulted in redis-
tribution of Huntingtin to FIP-2-positive vesicular struc-
tures, suggesting that FIP-2 participates in the targeting of
Huntingtin to these structures (Figure 2e,f). Likewise, the
expression of Rab8-67L with FIP-2 was also associated
with the colocalisation of these proteins (Figure 2g,h). In
contrast to Rab8-67L, the Rab8-22N mutant did not colo-
calise with FIP-2 (Figure 2i,j). Our results do not demon-
strate a direct interaction between Rab8 and Huntingtin,
but we could nonetheless show partial colocalisation of
these proteins in cotransfected cells (Figure 2k,l). Rab8
can presumably recruit Huntingtin to vesicular structures
with the help of endogenous FIP-2. Endogenous FIP-2
partially colocalised with the p115 protein, suggesting that
at least part of FIP-2 was associated with structures on the
Golgi complex (data not shown). We also saw endogenous
FIP-2 on vesicles, where it partially colocalised with an
enhanced GFP (EGFP)–Rab8 fusion (data not shown). 
Rab8 is an extraordinary Rab protein in that it promotes
radical changes in the cell shape by reorganising actin and
microtubules [5]. In accordance with this, we observed that
the expression of wild-type Rab8 or Rab8-67L polarised
HT1080 cells; the polarisation was characterised by the for-
mation of leading and trailing edges. High-level expression
of these proteins resulted in the formation of neurite-like
extensions (Figure 3b), whereas cells expressing Rab8-22N
were more symmetric (Figure 3a). Because FIP-2 and
Huntingtin directly and indirectly bind to Rab8, it is con-
ceivable that they might play a role in modulating cellular
morphogenesis. Expression of Huntingtin1–588 did not
notably change the cell shape (Figure 3c), but moderate
expression of FIP-2 promoted the formation of extended
lamellar and tail structures, and we observed formation of
extended protrusions in cells expressing higher levels of
FIP-2 (Figure 3d). This FIP-2-mediated change in cell
shape was inhibited by Rab8-22N, suggesting that FIP-2
might act upstream of Rab8 (data not shown).
Several studies have proposed that Huntingtin participates
in processes mediating vesicle trafficking [2,3]. Our results
provide further evidence for this by showing that Hunt-
ingtin is indirectly linked to the small GTPase, Rab8.
Huntingtin has been shown to localise to the plasma mem-
brane, the trans-Golgi network and to vesicles in the cyto-
plasm [3]. Interestingly, a similar intracellular distribution
has also been shown for Rab8 [5,10]. Moreover, we have
shown here that coexpression of Huntingtin and
Rab8–GTP results in partial colocalisation to a perinuclear
region. The FIP-2 protein most likely mediates this colo-
calisation as, according to our results, FIP-2 binds both
Huntingtin and Rab8. Furthermore, FIP-2 promoted relo-
calisation of cytosolic Huntingtin to vesicular structures. 
Rab8 modulates cellular morphogenesis by a currently
unknown mechanism. Our finding that a Rab8-binding
protein, FIP-2, associates with Huntingtin may offer
some clues. It has recently been shown that the expres-
sion of the Huntingtin-binding protein HAP-1 in PC12
cells promotes neurite extension [11]. Moreover, coex-
pression of a mutant Huntingtin protein with HAP-1
inhibits this process. The fact that FIP-2, another Hunt-
ingtin-binding protein, also modulates changes in the cell
shape strongly support a function for Huntingtin in
processes controlling cell morphogenesis. HAP-1 links
Huntingtin to the p150Glued subunit of dynactin, suggest-
ing that Huntingtin is present in a protein complex that is
required for motility of membrane organelles along
microtubules [12]. HAP-1 also binds to a Trio-like
polypeptide with a Rac1 guanine nucleotide exchange
factor domain that is involved in controlling actin dynam-
ics [13]. Furthermore, Huntingtin interacts with HIP1, a
protein that links membrane vesicles to the actin
cytoskeleton [14]. Whether the FIP-2-induced cell polar-
isation is mediated through these Huntingtin-binding
proteins or by other Rab8-binding proteins awaits further
studies. However, the fact that FIP-2 is induced by
TNF-α suggests that it could mediate this signal through
Rab8 [6]. This is an intriguing possibility because
Rab8–GTP also binds another protein, Rab8ip/germinal
centre kinase (GCK), which is activated by TNF-α [15].
Thus, it is likely that Rab8 plays a central role in mediat-
ing responses to stress.
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Figure 3
The effects of FIP-2, Huntingtin and Rab8 mutants on cellular
morphogenesis. HT1080 cells were transiently transfected,
with separate constructs encoding (a) Rab8-22N, (b) Rab8-67L,
(c) Huntingtin and (d) FIP-2. After 16 h, cells were fixed with 4%
paraformaldehyde, permeabilised with triton X-100, stained with the
appropriate antibodies and analysed by immunofluorescence
microscopy. Arrows indicate the presence of extensive processes,
while arrowheads indicate protrusion and tail structures. The scale
bars represent 20 µm.
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Although the cell biological function of Huntingtin is still
unknown, some evidence implicates an important role for
Huntingtin in apoptosis [16]. This is also suggested by the
fact that overexpression of wild-type Huntingtin protects
cells from a variety of apoptotic stimuli [17]. How this
anti-apoptotic effect of Huntingtin is achieved is still not
clear. FIP-2 interacts with the adenoviral E3-14.7K
protein, which protects cells from TNF-α’s cytolytic activ-
ity [6]. Interestingly, both the E3-14.7K protein and Hunt-
ingtin bind the carboxy-terminal region of FIP-2. Thus,
the intriguing possibility exists that the binding of Hunt-
ingtin to FIP-2 could counteract cytolytic signals mediated
through FIP-2. This possibility is in agreement with
recent results showing that expression of mutant Hunt-
ingtin increases the expression of several inflammatory-
related mRNAs [18]. 
Supplementary material
Supplementary material including additional methodological detail is
available at http://current-biology.com/supmat/supmatin.htm.
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